129 related articles for article (PubMed ID: 36437707)
1. Evaluation of hematological parameters in patients using systemic isotretinoin with diagnosis of acne vulgaris.
Demirci Saadet E; Sahin U
J Cosmet Dermatol; 2023 Mar; 22(3):1077-1082. PubMed ID: 36437707
[TBL] [Abstract][Full Text] [Related]
2. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris.
Seçkin HY; Baş Y; Takçı Z; Kalkan G
Cutan Ocul Toxicol; 2016; 35(2):89-91. PubMed ID: 25853176
[TBL] [Abstract][Full Text] [Related]
3. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
Kutlu Ö
Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
[No Abstract] [Full Text] [Related]
4. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin?
Tamer F; Yuksel ME; Avcı E
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):65-69. PubMed ID: 31233169
[TBL] [Abstract][Full Text] [Related]
5. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients?
Önder S; Ozturk M
Cutan Ocul Toxicol; 2020 Jun; 39(2):111-114. PubMed ID: 32100587
[No Abstract] [Full Text] [Related]
6. Evaluation of sequential effect of isotretinoin on the haematological parameters in patients with acne vulgaris.
Gencoglan G; Inanir I; Miskioglu M; Gunduz K
Cutan Ocul Toxicol; 2018 Jun; 37(2):139-142. PubMed ID: 28743196
[TBL] [Abstract][Full Text] [Related]
7. Effect of isotretinoin treatment on inflammatory and hematological parameters in patients with acne vulgaris.
Esen M
Cutan Ocul Toxicol; 2024 Mar; 43(1):27-32. PubMed ID: 37837334
[TBL] [Abstract][Full Text] [Related]
8. Investigation of relapse rate and factors affecting relapse after oral isotretinoin treatment in patients with acne vulgaris.
Demirci Saadet E
Dermatol Ther; 2021 Nov; 34(6):e15109. PubMed ID: 34431590
[TBL] [Abstract][Full Text] [Related]
9. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris.
Cosansu NC; Yuksekal G; Turan U; Umitfer F; Yaldiz M; Sevimli Dikicier B
Cutan Ocul Toxicol; 2022 Jun; 41(2):174-178. PubMed ID: 35658795
[TBL] [Abstract][Full Text] [Related]
10. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
Öktem A; Hayran Y; Arı E; Yalçın B
J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
[No Abstract] [Full Text] [Related]
11. Evaluation of oral isotretinoin effects on hearing system in patients with acne vulgaris: Reversible or not?
Kemeriz F; Kayabaşı S; Cevirgen Cemil B; Hızlı Ö
Dermatol Ther; 2021 Jan; 34(1):e14640. PubMed ID: 33278063
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the changes in sebum, moisturization and elasticity in acne vulgaris patients receiving systemic isotretinoin treatment.
Gencebay G; Aşkın Ö; Serdaroğlu S
Cutan Ocul Toxicol; 2021 Jun; 40(2):140-144. PubMed ID: 33978534
[TBL] [Abstract][Full Text] [Related]
13. Effects of isotretinoin on the platelet counts and the mean platelet volume in patients with acne vulgaris.
Ataseven A; Ugur Bilgin A
ScientificWorldJournal; 2014; 2014():156464. PubMed ID: 24605049
[TBL] [Abstract][Full Text] [Related]
14. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients.
Hareedy MS; Tawfik KM
J Cosmet Dermatol; 2022 Nov; 21(11):6191-6198. PubMed ID: 35770307
[TBL] [Abstract][Full Text] [Related]
15. Isotretinoin is safe and efficacious in Asians with acne vulgaris.
Gan EY; Koh WP; Jin AZ; Tan AW; Tan HH; Tang MB
J Dermatolog Treat; 2013 Oct; 24(5):387-91. PubMed ID: 22390469
[TBL] [Abstract][Full Text] [Related]
16. A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII).
Turan Ç; Metin N
Curr Health Sci J; 2022; 48(1):63-67. PubMed ID: 35911945
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thyroid function tests of acne vulgaris patients treated with systemic isotretinoin.
Yıldırım N; Doğan S; Atakan N
J Dermatolog Treat; 2017 Mar; 28(2):141-144. PubMed ID: 27425198
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
19. The oral adverse effects of isotretinoin treatment in acne vulgaris patients: A prospective, case-control study.
Erdemir U; Okan G; Gungor S; Tekin B; Yildiz SO; Yildiz E
Niger J Clin Pract; 2017 Jul; 20(7):860-866. PubMed ID: 28791981
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
Boyraz N; Mustak PK
Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
